
Healthcare · BSE
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Price Band
₹101
Issue Size
₹35.34 Cr
Lot Size
1200 shares
GMP
+2.0%
Est. Listing
₹103
at current GMP
Subscribed
1.34x
overall
Open
26 Sep 2022
Close
29 Sep 2022
Allotment
4 Oct 2022
Refund
5 Oct 2022
Demat Credit
6 Oct 2022
Listing
10 Oct 2022
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹101
Band: ₹101
Estimated Listing Price
₹103
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,21,200
Estimated Profit / Lot
₹2,400
1200 × ₹2
Grey Market Premium trend
+₹2
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹2 | 2.0% | ₹103 |
| 30 Oct 2026 | +₹2 | 2.0% | ₹103 |
| 29 Oct 2026 | +₹2 | 1.8% | ₹103 |
GMP is unofficial market data. Not a guarantee of listing performance.
Trident Lifeline Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹35.34 Crores. The shares are offered at a price band of ₹101 to ₹101 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,21,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-10-06, while un-allotted funds or UPI block mandates will be released on 2022-10-05.
The latest grey market premium for Trident Lifeline Limited IPO is ₹2, which indicates an expected listing price of ₹103.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.